Cargando…
Long-term outcomes of transcutaneous retrobulbar amphotericin B in COVID-19-associated mucormycosis
PURPOSE: To describe the long-term outcomes of transcutaneous retrobulbar amphotericin B (TRAMB) in COVID-19-associated mucormycosis. METHODS: In total, 18 cases of COVID-19-associated mucormycosis were reviewed. In addition to the recommended treatment protocol, all patients were to be given 3.5 mg...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228905/ https://www.ncbi.nlm.nih.gov/pubmed/36727338 http://dx.doi.org/10.4103/ijo.IJO_1382_22 |